Gilead Sciences, Inc. (NASDAQ: GILD) - Inspection Records
Inspection records and compliance data for Gilead Sciences, Inc. in Foster City, California. 17 FDA inspections on record, last inspected January 16, 2026. Publicly traded as NASDAQ: GILD.
This profile covers Gilead Sciences, Inc. based in Foster City, California, United States.
FDA Inspection History
- FDA inspections
- 17
- OAI
- 0
- VAI
- 11
- NAI
- 5
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected December 4, 2009. Last inspected January 16, 2026.
Most cited issue areas
- Late submission of 15-day report2 inspections
- Electronic records1 inspection
- FDA access to sponsor records1 inspection
Most recent inspections
| Date | Classification | Office | Project area |
|---|---|---|---|
| January 16, 2026 | NAI | Bioresearch Monitoring | |
| January 29, 2025 | Not classified | San Francisco District Office | |
| January 22, 2024 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 18, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 22, 2020 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
... and 10 more documents
Companies with similar regulatory profiles, compliance history, and operations.
No related companies are listed in the preview. Use search below to find similar companies or view the full directory for this location.
Name
Gilead Sciences, Inc.
Stock ticker
GILD
Exchange
NASDAQ
Share price
$153.57
Market cap
$190.4B
Price as of
October 22, 2026
FEI Number
1000523075
State
California
City
Foster City
ID: 05c4ed0b-5c05-4c0e-996e-9e344fef905c